Researchers is demonstrably improved this course of the novel therapy for amyloid heart disease, utilizing the compound. Early clinical data indicates potential benefits for patients suffering by a serious disease. This effort highlights BridgeBio's dedication to treating significant healthcare demands in the cardiology field. Attruby: BridgeBio's